What if melatonin could help patients with severe COVID-19?

Sánchez-González, Miguel Ángel; Mahíllo-Fernández, Ignacio; Villar-Álvarez, Felipe; Llanos, Lucía

Sánchez-González, Miguel Ángel; Mahíllo-Fernández, Ignacio; Villar-Álvarez, Felipe; Llanos, Lucía.

Sánchez-González MÁ; Psychiatry Department, Fundación Jiménez Díaz University Hospital, Health Research Institute (IIS-FJD, UAM), Madrid, Spain.
Mahíllo-Fernández I; Department of Anatomy, Histology, and Neuroscience, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
Villar-Álvarez F; Biostatistics Unit, Fundación Jiménez Díaz University Hospital, Health Research Institute (IIS-FJD, UAM), Madrid, Spain.
Llanos L; Pulmonology Department, Fundación Jiménez Díaz University Hospital, Health Research Institute (IIS-FJD, UAM), CIBERES, Universidad Autónoma de Madrid, Madrid, Spain.

J Clin Sleep Med ; 18(1): 335-336, 2022 01 01.

Article in English | MEDLINE | ID: covidwho-1318451

Subject(s)

COVID-19; Melatonin; Antioxidants; Humans; Melatonin/therapeutic use; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Melatonin Limits: Humans Language: English Journal: J Clin Sleep Med Year: 2022 Document Type: Article Affiliation country: Jcsm.9554

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google